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Abstract
Background: Since 2015, pharmacists have been integrating into English general practices and more recently into
primary care networks. General practice-based pharmacists provide a range of patient-facing services, such as
medication reviews, management of long-term conditions and minor ailments, prescribing duties and answering
queries over the telephone. Literature reports patients’ satisfaction with general practice-based pharmacists’ services,
however, previous research captured only limited experiences. The aim of the current study was to pursue an
extensive exploration of patients’ experiences of pharmacists in general practice.
Methods: General practice-based pharmacists, working in practices in West London, Surrey and Berkshire, handed
invitation packs to patients seen during consultations. Patients that wanted to take part in the study were invited to
undertake a qualitative, in-depth, face-to-face, semi-structured interview within the practice with which each patient
was registered. Interviews lasted from 15min to more than 1 h and were audio-recorded. Recruitment continued
until data saturation. Audio-recordings were transcribed verbatim and transcripts analysed thematically.
Results: Twenty participants were interviewed. Four themes were discerned: awareness (“I had been coming to this
practice for 24 years and I didn’t know that there was a pharmacist”); accessibility (“People ring for a GP [general
practitioner] appointment … it’s Monday and they [receptionist] tells you ‘We can slot you in on Friday’ … with a
pharmacist on board, they can [instantly] look at you”); interactions (“I’ve always had a really good interaction with
them [pharmacists] and they listen and they take on board what I’m trying to say”); and feedback (“It’s easier [to
collect feedback instantly] because I could have forgotten half of what they [pharmacists] have told me in an hour
or so’s time”).
Conclusions: Findings indicate that pharmacists’ integration into general practices could improve accessibility to,
and the quality of, care received. The findings will assist policy development to provide general practice-based
pharmacists’ services as per patients’ needs.
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Background
English general practices have been facing ongoing
workload pressures stemming from an ageing population
and reductions in the general practitioner (GP) work-
force [1]. As a result, patients have been experiencing
decreased access to primary care services, which has
subsequently led to high levels of dissatisfaction [2–4].
To tackle these problems, and in parallel exploit the in-
creasing numbers of qualified pharmacists [5, 6], there
has been a wide drive to integrate pharmacists into gen-
eral practices. Efforts to integrate pharmacists began
with a two-phased scheme between 2015 and 2019, sup-
ported by the National Health Service (NHS), that intro-
duced approximately 1000 general practice-based
pharmacists in England [7]. In early 2019, the NHS Long
Term Plan was announced that urged general practices
to form Primary Care Networks (PCNs) [8]. PCNs are
collaborative entities linking primary care services with
hospital, social care and voluntary sector organisations
and covering populations between 30,000–50,000 people
[9]. PCNs are expected to hire about 26,000 additional
staff by 2023/24, including large numbers of pharma-
cists, with employment costs fully reimbursed by NHS
England [10]. Each of the approximately 1260 PCNs is
expected to have at least one pharmacist by 2020 [11].
The projection is that by 2023/24, a typical PCN will
have about five pharmacists, raising the total number of
general practice-based pharmacists across England to
about 7000 [12, 13]. A typical practice serving 10,000 pa-
tients is anticipated to have a pro-rata coverage by a
pharmacist for 12 h per week [12].
Official statistics from NHS England show that in Sep-
tember 2020 there were 1582 full-time equivalent gen-
eral practice-based pharmacists in England compared to
1249 in September 2019, which translates to an increase
of 26.7% [14]. Despite the increase in the total number
of general practice-based pharmacists, approximately
50% of the general practices in England did not have a
pharmacist in early 2020 [15]. In addition, only half of
the PCNs recruited a pharmacist in 2019 [16]. By the
end of June 2020, 24% of the PCNs were still to claim
funds from NHS England to hire a pharmacist [17]. The
proposed reasons as to why a significant proportion of
PCNs have not recruited a pharmacist included insuffi-
cient numbers of appropriately qualified pharmacists for
the posts, low pay grades that discourage pharmacists
from taking posts in PCNs, uncertainty of PCNs on how
to effectively use the skills of a pharmacist and the re-
cent pandemic [15, 17, 18]. As a result, there are claims
that the expected targets with regards to general
practice-based pharmacists’ numbers might be impos-
sible to be achieved [15].
Common roles of English general practice-based phar-
macists include face-to-face clinics with patients for
structured medication reviews and long-term condition
management; telephone consultations for minor ail-
ments and triage; prescribing duties, for those qualified;
and supporting staff in medication-related queries and
meeting targets of incentive programmes [19–21].
Several countries have attempted to implement general
practice-based pharmacists’ services, including Australia
[22], Canada [23], USA [24], New Zealand [25] and the
Netherlands [26]. In the UK, having pharmacists in gen-
eral practice is not an entirely new concept [27, 28]. This
is the first time, however, that the role is being imple-
mented to a large extent and so needs to be formally
tested [29]. Little is known about how the presence of
pharmacists in general practice impacts the wider
healthcare system, including patients and healthcare pro-
fessionals, and there have been ongoing calls for a thor-
ough exploration of the role [30–32].
Existing literature, both nationally [33–39] and inter-
nationally [40–45], has offered some insights into pa-
tients’ views of general practice-based pharmacists.
Some of these studies elicited opinions before patients
had any contact with a general practice-based pharma-
cist [44, 45]. Of the studies referring to views post con-
tact with a pharmacist [33–43], most described the
contentment of patients with pharmacists’ presence in
general practice as well as intentions to recommend
pharmacists’ services.
Previous research efforts in England, however, were
conducted some years ago and were limited to specific
geographical regions, hence unlikely to have accounted
for the whole range of employment models and roles of
general practice-based pharmacists. Additionally, the
waves of pharmacists still being integrated into English
general practices might translate to varying patients’ ex-
periences as a result of increasing exposure to pharma-
cists’ services as well as to diverse skillsets of
pharmacists. The aim of the current study was to pursue
an exploratory approach and explore patients’ experi-
ences of general practice-based pharmacists in three dif-
ferent locations in England and therefore contribute to a
more universal mapping of experiences. In particular,
the current study set out to answer the following re-
search question: What are the patients’ experiences and
views of pharmacists working in general practice?
Methods
Study design
A realistic qualitative interview design was chosen to
allow for an in-depth exploration of experiences, using
interpretive thematic analysis.
Setting
Participants were recruited from large general practices
located in West London, Surrey and Berkshire, targeted
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as recruitment points due to working connections with
the research team’s organisation. The West London
practice, with a list of approximately 16,000 registered
patients, has participated in the ‘pharmacists in general
practice’ scheme since inception. This practice was com-
posed of two sites and, at the time of the study, had 12
GPs, four nurses and three pharmacists. Pharmacists (in
total) served approximately 170 patients per week, both
through face-to-face and telephone sessions. Practices in
Surrey and Berkshire were not part of the initial scheme
but at the time of data collection they also employed
pharmacists. The practice in Surrey was composed of a
single site, had 16,000 patients registered and 13 GPs,
two trainee GPs, five nurses and one pharmacist. The
pharmacist dealt with approximately 100 patients on a
weekly basis (both face-to-face and over the telephone).
The practice in Berkshire consisted of two sites, had 14,
000 registered patients and employed nine GPs, two
nurses and two pharmacists. Pharmacists there served
approximately 60 patients per week in total, both via
face-to-face and telephone appointments.
Recruitment
A purposive sampling approach was followed to recruit
people who have visited a pharmacist in general practice.
General practice-based pharmacists, working in the
above-mentioned practices, handed invitation packs to
eligible patients they met during consultations. Patients
were eligible if they were aged 16 years or over, English
speakers and able to consent for themselves as deter-
mined by the recruiting pharmacist. Invitation packs
contained the study’s invitation letter; information sheet,
providing details of the study and research team; consent
form; reply form; and a business reply envelope. The
study’s documents asked potential participants to dir-
ectly contact a member of the research team (GDK), ei-
ther via email or by filling in the reply form and posting
it within the pre-paid envelope. GDK is a doctoral re-
search student with experience in qualitative research.
Once interest for participation was expressed, GDK con-
tacted potential participants and a mutually convenient
time for the interview was arranged. No other reminders
were sent. Recruitment continued until data saturation.
The research team interpreted data saturation as the
point in data collection at which no new information
was discernable, also known as ‘informational redun-
dancy’ [46–48]. When this point was reached, four more
interviews were conducted before recruitment ceased.
Data collection
Recruitment and data collection took place between De-
cember 2018 and February 2020. Involvement in the
study was voluntary and without monetary incentives.
Audio-recorded interviews were conducted by GDK in
private meeting or consultation spaces within the gen-
eral practice with which each participant was registered.
Just before each interview, mutual introductions took
place to establish rapport and any questions that partici-
pants had were answered. In addition, the confidentiality
of the interviews was highlighted by emphasising that
discussions could not be overheard by general practice-
based pharmacists, that findings would only be discussed
between the research team without any disclosure to
pharmacists and that any data to be used in research
outputs would be anonymised. All interviews were face-
to-face and semi-structured. An interview schedule, con-
sisting of some open-ended questions and prompts, was
used. The interview schedule was developed exclusively
for this study and can be found as an additional file (see
Additional file 1). Interviews terminated only when par-
ticipants did not have anything else to add. Interviews
lasted from 15min to more than 1 h. Demographic in-
formation was collected at the time of interview.
Data analysis
Audio-recordings were transcribed verbatim half by
GDK and half by a professional transcribing agency, a
sub-set of the latter was checked for accuracy by GDK.
Transcripts were analysed thematically by following the
steps of Braun and Clark (data familiarisation, data cod-
ing, identifying themes, re-examining themes, defining
and naming themes and synthesising the report) [49].
Data was inductively [50] coded by GDK with the aid of
NVivo 11 software, and a single code was ascribed to
every different idea. Coding was verified by the whole re-
search team via debriefing meetings in which thorough
discussions took place. Data under the same code was
collated together and sorted into categories, which were
then re-examined and collapsed into possible themes
with associated subthemes. The research team collect-
ively assessed, refined and named the themes, again dur-
ing debriefing meetings. Participants’ feedback on
transcripts or findings was not sought.
Results
Twenty participants were interviewed in total. There was
an equal proportion of male to female participants. All
had some contact with a general practice-based pharma-
cist. Participants were from different age-groups but all
were aged 40 years or older. Most were from a white
British and other white backgrounds. Table 1 provides
an overview of participants’ demographics.
Themes
Four predominant themes were discerned in the data:
awareness; accessibility; interactions; and feedback. Fig-
ure 1 provides an overview of the themes and associated
sub-themes.
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Theme 1: awareness
Most participants claimed that patients were largely ig-
norant of the presence of pharmacists in general practice
due to a perceived absence of relevant information ma-
terial. They all realised by chance the existence of gen-
eral practice-based pharmacists, just before or only at
the time of consultation.
I had been coming to this practice for 24 years and I
didn’t know that there was a pharmacist here. It’s
possibly not my fault, they don’t advertise, promote,
they don’t explain enough … I got a text [message]
saying “make an appointment with the pharmacist”
… [I was thinking] “What are they talking about”?
“Where”? (Participant 5)
There was also uncertainty, and often confusion, about
the roles of general practice-based pharmacists and
whether or not contact would be ongoing.
I still don’t know why a patient would want to see a
pharmacist in the general practice. I can’t get my
Table 1 Demographics of participants
Age-group (years) Number of visits to the
pharmacist in general practice*
Ethnicity Location from where
participants were recruited
Patients (n = 20) 40–49 (n = 2)
50–59 (n = 5)
60–69 (n = 5)
70–80 (n = 6)
80+ (n = 2)
1 to 12 times White British (n = 13)
White Irish (n = 3)
Other White (n = 2)
Arab (n = 1)
Other Asian (n = 1)
West London (n = 7)
Surrey (n = 9)
Berkshire (n = 4)
*This does not include contact over the telephone
Fig. 1 Themes and subthemes of patients’ experiences of pharmacists in general practice
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head around that. ‘Cause if I want to ask the
pharmacist something I go into the actual pharmacy.
I’m not aware of the full extent of what they do.
(Participant 10)
Nearly all participants emphasised the need to promote
the presence of pharmacists in general practice, to raise
patients’ awareness and therefore encourage the uptake
of pharmacists’ services. Numerous methods of promo-
tion were proposed, such as television advertisements;
messages on practice websites, social media accounts,
waiting room screens and noticeboards, including intro-
ducing the pharmacist amongst the healthcare team
photographs; posters and leaflets; and establishing visible
consultation spaces for pharmacists.
Word of mouth was largely seen as an effective way to
promote services, including through outreach activities
and referrals.
I have three housemates registered in this practice
and I can spread it by mouth, “You know that
there’s a pharmacist that attended to me today, they
helped me a lot by giving me information”. (Partici-
pant 13)
If a GP feels “well, this particular problem would be
better decided by a pharmacist” [then they should]
refer. But that doesn’t seem to happen very often.
(Participant 20)
Apart from the existence of general practice-based phar-
macists, additional information needs of patients in-
cluded the specific services offered by pharmacists;
reasons to contact pharmacists; what is outside the phar-
macist’s remit; and the potential benefits of seeing the
pharmacist.
Theme 2: accessibility
General practice-based pharmacists were perceived, by
several participants, to be readily available to take pa-
tients’ queries over the telephone, in contrast to GPs
who were much more difficult to contact.
The receptionist says “Oh yes, the [pharmacist is] in
today. I’ll just ask them to chat to you”, and it’s done
within a day. Or the reception will say, “They’re not
in today but they’ll be in tomorrow and I’ll get them
to call you”. (Participant 15)
Similarly, some participants claimed that there was far
less waiting time with pharmacists’ appointments, both
with scheduling an appointment and in the waiting
room. There were some suggestions that seeing the
pharmacist should become the first stage when an ap-
pointment at the practice is required.
People ring for a GP appointment and they can be
at death’s door … [and] it’s Monday and they [re-
ceptionist] tells you “We can slot you in on Friday”.
With a pharmacist on board, they can [see] you and
if it’s something more serious they would speak to
the doctor. It’s a faster system … you could have an
11 o’clock appointment for a GP and you won’t be
seen until 12-12.30. With the pharmacist, it may
run over five minutes, it may be ten minutes but no
more than that. (Participant 1)
A few participants, however, reported occasional difficul-
ties in getting appointments with pharmacists covering
multiple practices, due to reduced availability and/or un-
certainty about the exact days pharmacists were present
in a specific practice. Likewise, one participant was frus-
trated not to directly be put through to the pharmacist,
as phone calls were often returned at inconvenient
times. Another one complained about pharmacists
sometimes cancelling their appointments last moment.
Some participants called for larger numbers of pharma-
cists, weekend sessions, appointments on the same day
as GP appointments and availability of drop-in clinics.
Some participants mentioned that contact with the
pharmacist should always be offered as a choice to the
patient, in triage and online booking systems.
[Seeing] the pharmacist should be an equal oppor-
tunity [to the GP], a choice for patients. Even if you
went through a telephone screening … [also] to have
an online booking system which would incorporate
the pharmacist. (Participant 3)
Theme 3: interactions
The vast majority of participants emphasised the high
quality of the interactions they had with general
practice-based pharmacists. They reported that their
consultation with a pharmacist was a two-way inter-
active process. Pharmacists were believed to treat pa-
tients as equal fellow-speakers, rather than passive
recipients of instructions, and to welcome patients’
thoughts and questions.
I have colitis [and] I have a suspicion that it is trig-
gered by sugar. I tried to have a discussion with the
doctor but they didn’t want to discuss it, they just
said, “There is no research on that at all”. At my last
meeting with the pharmacist here, I mentioned it to
them. They had a really useful discussion with me
about it. And I came away feeling that I had been
listened to. I felt that I had an informed and adult
discussion. With the doctor, often they treat you like
children “the doctor knows best, this is what you’re
gonna [do]”. (Participant 2)
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The perceived absence of hierarchies and judgemental
approaches by nearly all participants made them feel at
ease with pharmacists and established mutual familiarity
and relationships.
Well sometimes when you come to the doctor, I am
always conscious of the time and I don’t waffle. I
don’t just waste the doctor’s time … So, there’s a cer-
tain level of anxiety, stress ... I found that with the
pharmacist there was a less judgemental attitude,
they were very approachable, immediate, very easy
to talk to. (Participant 6)
The pharmacist, I’ve seen them once and I feel
like I’ve known them for a long time. That’s un-
usual ... I know the pharmacist’s name. That’s the
difference. I’ve seen loads and loads of doctors
here, more than once, and I don’t know their
names. (Participant 3)
Pharmacists, several participants claimed, visually con-
nected with patients during consultations, which they
took as an expression of being paid attention to.
They [pharmacist] looked me straight in the eye
and I think sometimes if you’re not looking at
someone, you’re probably wandering with your
mind, whereas, they were concentrating on me.
(Participant 12)
Many participants emphasised the caring attitude of
pharmacists, which they attributed to fewer time-
constraints compared to GPs.
They [pharmacists] are very dedicated in what they
do, they’re empathetic … the doctors, once the ten
minutes are up, they stand up [and] you haven’t
even finished and you have to go. I hate that. I think
that’s dreadful. (Participant 8)
Several participants claimed that, as a result of longer
appointment times, pharmacists were thorough in their
approach, including concomitantly managing multiple
co-ailments and developing structured care plans.
I had a new set of blood tests done which showed
that my cholesterol levels had increased … They
[pharmacist] went through my lifestyle, diet, exercise,
where I live … They were thorough … [and] set a
good plan to go forward, [to] have a review after
three months and see how we go … I [also] had some
twitching in my calf muscle, they weren’t quite sure
what it was, so they saw one of the GPs in the prac-
tice and chased it through with them. (Participant 7)
One participant, however, was afraid that pharmacists
occasionally exceeded competency and requested more
referrals to specialist care.
Pharmacists were reported, by several participants, to
always review every single medication patients had, re-
gardless of whether they related to the presenting
complaint.
The [pharmacist] went through my list of other med-
ications [as well] and dismissed the ones that I
didn’t really need to keep on my repeat because I
wasn’t having them … They said “Let’s take them off
because if you do need them in the future, they can
be put back on again”. No GP has ever said that to
me before. So, you can see how older people just have
this long list of medications that they may, if they
don’t realise, still be taking. (Participant 17)
Nearly all participants emphasised the information/ex-
planation that pharmacists provided, including the ana-
lytical way this was conveyed, which was seen to allow
patients to fully understand their medication or condi-
tion and convince them to accept the pharmacist’s
advice.
The [pharmacist] has given me some reading mater-
ial to take away with regards to possible injection
[for my diabetes]. They showed me with a dummy
pen how it would be administered. So, yeah, it was
very informative. They took the time to actually ex-
plain [everything] … the book of information, they
took the time to actually go through the pages, give a
brief outline, how it may or may not influence me.
(Participant 14)
Conversely, a few participants stated that pharmacists
should consider potential side effects of medications up-
front (rather than trailing different medications) and ex-
plain everything about medications without having to be
prompted. One participant mentioned that pharmacists
should also consider alternative therapies, such as nat-
ural substances and homeopathic remedies. Another
participant was disappointed about pharmacists not re-
cording condition−/medication-related history, hence
having to re-provide these details in subsequent
consultations.
All participants left consultations with pharmacists
feeling confident, reassured and with peace of mind that
their problems had been resolved.
My fear was that the medical people were going to
keep pushing statins at me, regardless of my side ef-
fects. But they [pharmacist] said, “Look, we won’t try
any more”. So, I was reassured by the fact that I’m
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not going to be pushed statins forever and I feel com-
pletely reassured that my interests are being properly
looked after in terms of prescribing medication. (Par-
ticipant 11)
A lot of doctors made me feel quite a hypochondriac
… with the pharmacist, you feel a sense of security
after leaving them. (Participant 1)
Theme 4: feedback
Some participants doubted if patient feedback on general
practice-based services was taken seriously into
consideration.
Usually the feedback, the result of that doesn’t go
back to the people … Is that [feedback] making any
difference, is that making any improvement? Did
anybody read it? Has it been put in practice? (Par-
ticipant 4)
There was no consensus amongst participants on the
preferred way to collect patient feedback on general
practice-based pharmacists. Various means were pro-
posed, such as face-to-face interviews; questionnaire
forms, either as hard copies or online, including using
tick-boxes or rating scales or human faces mirroring sat-
isfaction level; and politely reporting concerns directly to
pharmacists. Most participants stated that the overall
process of feedback provision should be quick, to en-
courage participation. As such, participants claimed, any
feedback collection tool should be short in length.
The majority of participants also stated that feedback
should be collected straight after consultations.
It’s easier [to collect feedback instantly] because I
could have forgotten half of what [the pharmacist]
told me in an hour or so’s time. I’d go “What did
they say about my tablet”? … So, [it would be good]
to get at me [for feedback] quickly afterwards, while
I remember things. (Participant 19)
The public wants [to give feedback] right at the time
they are having the consultation … because if they
give [a form] to you, then you go back to your office
and you set it down and two or three days later you
have more things piled up and you never send the
feedback. (Participant 5)
Discussion
Findings indicate that patients are unaware of pharma-
cists’ presence in general practice and/or unclear when
to contact pharmacists. When they do interact with gen-
eral practice-based pharmacists, however, patients highly
appreciate the quality of care they receive. Some ways to
enhance the availability of pharmacists and collection of
patient feedback were suggested.
The findings of the current study could best be inter-
preted in light of ‘scientific realism’, which views ‘real-
ities’ in the contemporary world as meanings
constructed by human minds [51, 52]. The key feature
of ‘scientific realism’ is the element of explanation,
which is illustrated in the slogan question of ‘what it is
within a programme that works or does not work well,
for whom and under what circumstances’ [52, 53]. The
correlation between ‘scientific realism’ and our findings
lies in the fact that the current study identified strengths
and limitations with pharmacists’ presence in general
practice, as viewed by patients, through an exploratory
approach that sought to understand in-depth the reasons
of why certain aspects with pharmacists in general prac-
tice work or do not work for patients.
More simply, elements with pharmacists’ presence in
general practice that ‘work’ for patients include pharma-
cists’ availability, providing that pharmacists do not
cover many practices and patients consciously seek
pharmacists’ care; and the high standard of interactions,
which lead to positive emotions and a strong relation-
ship between patients and pharmacists, and occur when
there are no time-pressures during appointments. In
contrast, the aspect with pharmacists in general practice
that ‘does not work’ for patients is the existence of mul-
tiple information needs, due to the absence of relevant
information, which limit the uptake of pharmacists’
services.
Below, findings are related to pre-existing literature
whilst also taking into account current ‘social’ circum-
stances which could affect patients’ satisfaction with as-
pects of pharmacists’ presence in general practice.
Comparison with existing literature and realistic
discussion
The current study highlights the limited awareness of
pharmacists in general practice amongst patients. Previ-
ous UK research has also reported unawareness due to
absence of relevant communication from practices, in-
cluding patients not realising that they had a consult-
ation with a pharmacist, and confusion between
community and general practice-based pharmacists’
roles [34, 38]. Post publication of previous studies, our
findings imply that there is still no clear direction (either
at a central or local level) to inform the wider public
about general practice-based pharmacists’ existence,
what services they provide and how to access them.
Participants who consciously sought access to general
practice-based pharmacists’ services found pharmacists
more accessible than GPs, something that has also been
widely reported in literature [34, 36–38]. Our findings
indicate that pharmacists’ integration into general
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practices could fulfil the aim of offering patients
smoother access to healthcare services and checks, how-
ever, the achievement of this goal is largely hindered by
patients’ unawareness of the presence of in-house phar-
macists in practices. Moreover, a few of our participants
reported difficulties in accessing pharmacists covering
multiple practices, a phenomenon also noticed by pa-
tients in Australia [42]. Open-ended questions remain
about accessibility to pharmacists in the future. Firstly,
because pharmacists in PCNs are expected to work
across multiple practices [12, 21] and secondly, because
as awareness improves and demand increases, consult-
ation times are likely to decrease. In addition, increasing
numbers of remote consultations over the telephone
(following the coronavirus pandemic) [54] might restrict
pharmacists’ ability to respond to patients’ queries.
Our findings around the long duration and thorough-
ness of pharmacists’ consultations repeat those of previ-
ous studies [33–42]. The novelty of our study, however,
is that it also offers insight into the dynamics of interac-
tions between patients and general practice-based phar-
macists. These dynamics can be discussed using King
and Hoppe’s ‘6-function model’ [55], which is a
consensus-derived framework using six key functions to
understand ‘good approach’ in patient-practitioner en-
counters (see Table 2 for an overview of the model).
In our case, the function of ‘fostering relationships’
was achieved by suppressing hierarchies/judgements and
maintaining eye contact that established a welcoming
environment for patients and generated mutual bonds.
The function of ‘gathering information’ was illustrated
by pharmacists’ keenness to “listen to the patient” and
constant effort to collect details on condition or lifestyle
or medications, thereby avoiding unwarranted conclu-
sions and leaving patients feeling that they had been
heard. ‘Providing information’ was mirrored in the de-
tailed explanations, including using graphic and/or de-
scriptive means. ‘Decision making’ was indicated by the
absence of pressure on the patient to follow certain
treatments and the development of structured care
plans. ‘Enabling disease- and treatment-related behav-
iour’ was obvious in the better understanding of
medications patients developed post contact with the
pharmacist. The ‘responding to emotions’ function was
obvious in the caring attitude and reassurance offered by
pharmacists, and the opportunity for patients to speak
freely and express their concerns. Therefore, all key
functions of patient-centric communication were wit-
nessed in our findings. The absence of time constraints
contributed to the ability of pharmacists to interact at
this high level during consultations. It is unclear through
our findings, however, whether any skillset of pharma-
cists (different from those of GPs) also had some role to
play.
Last but not least, our study offered insight into patients’
preferences with regards to feedback collection. To help
action these insights, the patients could themselves be in-
volved in determining what type of feedback is required,
how it is collected and information disseminated. There is
ample literature describing involvement of patients at vari-
ous stages in research, such as in designing research prior-
ities, questions, methods, protocols and study
documentation as well as in data collection, analysis, inter-
pretation and dissemination [56–60]. Patient and public
involvement (PPI) often links with positive outcomes,
such as practical improvements in healthcare services
(ranging from informational material for patients to
changes in the delivery of services and the behaviours of
healthcare staff), increased participation rates in studies
and additional layers of understanding of research data
[56, 58, 61–64]. Despite the described benefits, PPI at-
tempts in research are not extremely common in the gen-
eral practice setting due to limited resources and fears of
complicating projects [65]. However, patient participation
groups (PPGs) in general practices are an easy way of
accessing PPI and could be actively involved in designing
and implementing a patient-friendly feedback mechanism
on general practice-based pharmacists’ services. Our find-
ings could act as a starting point to involve PPGs in feed-
back collection.
Strengths and limitations
The qualitative design used in the current study allowed
for an in-depth understanding of patients’ experiences.
Table 2 Overview of the ‘6-function model’, analysing ‘good approach’ in patient-practitioner interactions
Function of interaction Brief description
Fostering the relationship Refers to establishing rapport and connection between practitioner and patient.
Gathering information Refers to collecting as much information as possible from the patient to
understand their needs from the encounter.
Providing information Refers to offering information to the patient to facilitate understanding.
Decision making Refers to enabling patients’ deliberation and decision making, including developing
action plans.
Enabling disease- and treatment-related behaviour Refers to fostering self-management of the patient.
Responding to emotions Refers to showing empathy and assisting patients in developing positive emotions.
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The study was carried out at general practice settings di-
verse in terms of location and integration of pharma-
cists, hence the experiences captured are reflective of
some different models of employing pharmacists in gen-
eral practice and varied exposure of patients to pharma-
cists. Despite the limitations of ethnicity and age in the
sample (see below), sufficient data saturation was
achieved to offer findings a conceptual depth. We are
confident, therefore, that findings synthesise a wide (if
not the whole) range of potential experiences of patients
at the specific recruitment points. Findings primarily
apply to the UK reality, however, individual elements
will still be useful for international attempts to integrate
pharmacists into general practices.
We did not set out to include a representative sample
of the population in terms of age, ethnicity and region of
domicile. Participants were recruited only from three
practices in the south of England. As a result, findings
might not be fully generalisable but can provide insights
that could be extrapolated to other similar settings.
Moreover, participants who volunteered for interviews
mainly included white and older people, hence findings
do not offer a good representation of younger age-
groups and black and ethnic minorities who may have
different experiences. It could be that older patients are
most likely to face polypharmacy and other medication-
related problems and so use pharmacists’ services, hence
why younger patients were missing from our sample.
The fact that interviews were carried out inside general
practices might have introduced some biases in the re-
sponses of participants, due to a potential fear that phar-
macists would learn about participants’ views. We
believe, however, that the mutual trust established be-
tween the interviewer and participants and the reassur-
ance about the confidentiality of the study encouraged
the expression of honest views, hence making it very un-
likely that findings would have significantly differed if in-
terviews were carried out outside general practices.
Although the research team followed a reflexive ap-
proach by ignoring personal experiences and collectively
analysing data, because they are all pharmacists, some
unavoidable instances of personal assumptions during
data categorisation might still exist.
Implications
The specific implications of the current study are that
there is a need to:
 Appropriately educate patients and the public about
general practice-based pharmacists, including roles
and responsibilities.
 Ensure pharmacists are present in the practice for
an adequate amount of time each week, ideally on a
daily basis, and explicitly communicate rotas to
patients by also establishing an effective triage
system to prevent exhaustion of pharmacists’
resources.
 Secure the prerequisites for efficient interactions
with patients, for example, adequate appointment
lengths.
 Design a formal, quick and attractive feedback
mechanism for patients.
Future studies should employ maximum variation
sampling to include experiences of patients from differ-
ent ethnicities, ages, educational levels and regions of
domicile in the UK. Future studies should also include
developing additional measures to more thoroughly ex-
plore the added value pharmacists bring in general prac-
tice settings and co-designing pharmacists’ services with
the public, including developing interventions to satisfy
information needs with regards to pharmacists in gen-
eral practice.
Conclusions
The current study indicates that pharmacists’ integration
into general practice has the potential to enhance the
timely access to, and quality of, services in primary care.
Practitioners, including pharmacists themselves, can use
our findings to enhance their own practice by improving
patient-centred interactions during consultations. More
importantly, findings will inform delivery of the NHS
Long Term Plan on how to make best use, from a pa-
tient perspective, of general practice-based pharmacists
and will also assist practices when attempting to pro-
mote the benefits of having a pharmacist. Results will
also guide international policy about integrating pharma-
cists into general practices, including how to design and
evaluate patient-centric services.
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